Compare Coupang Inc (CPNG) vs CVS Health Corp (CVS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Coupang Inc vs CVS Health Corp — how do they compare? Coupang Inc trades at $16.54 (market cap $29.66B), while CVS Health Corp trades at $94.19 (market cap $119.58B). The key difference: CVS Health Corp is far larger — about 4× Coupang Inc's market cap, and CVS Health Corp pays a 2.84% dividend while Coupang Inc pays none. Which is the better fit depends on your goals.
| CPNG | CVS | |
|---|---|---|
Market Cap | $29.66B | $119.58B |
Sector | Consumer Cyclical | Health |
52-Week High | $33.53 | $110.60 |
52-Week Low | $15.12 | $65.51 |
Enterprise Value | $29.18B | $181.93B |
Dividend Yield | — | 2.84% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
CPNG trades at $16.55, up 2.22% today, with a neutral technical signal and bearish moving averages. Revenue grew to $34.53B in 2025, but recent quarters missed EPS expectations, and 2026 projects a net loss. The stock is undervalued relative to analyst consensus targets near $23.38, supported by strong cash flow from operations of $1.77B in 2025.
Outlook remains mixed due to near-term profitability challenges, but long-term growth in South Korean e-commerce and expansion into Taiwan offer upside. Risks include competitive pressures, regulatory fines, and execution on margin improvement. Analyst sentiment is overwhelmingly bullish with 87.5% buy ratings.
CVS Health trades at $94.12, down 1.62% today, but maintains strong analyst support with 33 buy ratings and a $115.90 consensus price target. The company delivered three consecutive earnings beats in 2026, with Q2 EPS of $2.58 beating expectations by 38%. Technical indicators show mixed signals with bullish oscillators but bearish moving averages, while fundamentals reveal solid revenue growth to $402.07B in 2025 despite margin compression.
CVS presents a compelling value opportunity with attractive valuation ratios (P/S: 0.29, P/B: 1.5) and strong institutional confidence. Near-term catalysts include continued Aetna recovery and healthcare services expansion, though risks include 2027 PBM pressures and margin volatility. The stock offers 23% upside to analyst targets with defensive healthcare positioning.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Coupang Inc
Coupang Inc is an e-commerce company. The company sells apparel, electronics, footwear, food products, furniture, nutritional supplements, and other products. Its segments include Product Commerce and Growth Initiatives.
Read more on CPNG →About CVS Health Corp
Following its acquisition of Aetna in late 2018, CVS Health now provides an even more integrated healthcare-services offering for its members. Legacy CVS combined both the largest pharmacy benefit manager, processing over 2 billion adjusted claims annually, and a sizable pharmacy operation, including nearly 10,000 retail pharmacy locations primarily in the U.S. Adding a managed-care organization with 24 million medical members gives the company a strong position in the insurance industry and should help CVS better control overall healthcare costs for its clients.
Read more on CVS →
